Branford, CT, United States of America

LuYan Zhang


Average Co-Inventor Count = 8.0

ph-index = 2

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2005-2012

Loading Chart...
2 patents (USPTO):

Title: LuYan Zhang: Innovator in C5a Receptor Modulation

Introduction

LuYan Zhang is a notable inventor based in Branford, CT (US), recognized for his contributions to the field of pharmaceutical sciences. He holds two patents that focus on innovative compounds aimed at modulating C5a receptor activity, which is crucial in treating various inflammatory and immune system disorders.

Latest Patents

Zhang's latest patents include "Aryl imidazoles and related compounds as C5a receptor modulators." This invention provides packaged pharmaceutical preparations of aryl-substituted imidazoles, pyrazoles, pyridizines, and related compounds. These compounds serve as ligands for C5a receptors, exhibiting high affinity and demonstrating neutral antagonist or inverse agonist activity. The invention also encompasses pharmaceutical compositions that utilize these compounds for treating a range of inflammatory and immune system disorders.

Another significant patent is "Substituted tetrahydroisoquinolines as C5a receptor modulators." This patent presents substituted tetrahydroisoquinolines and related compounds that can modulate C5a receptor activity both in vivo and in vitro. These compounds are particularly beneficial for treating conditions linked to pathological C5a receptor activation in humans, domesticated companion animals, and livestock. The patent also details pharmaceutical compositions and methods for utilizing these ligands in receptor localization studies.

Career Highlights

Throughout his career, LuYan Zhang has worked with prominent companies in the pharmaceutical industry, including Neurogen Corporation and Novartis International Pharmaceutical, Ltd. His experience in these organizations has significantly contributed to his expertise in drug development and receptor modulation.

Collaborations

Zhang has collaborated with notable colleagues, including Scott A. Mitchell and He Zhao, who have contributed to his research and development efforts in the field.

Conclusion

LuYan Zhang's innovative work in C5a receptor modulation has the potential to advance treatments for various inflammatory and immune disorders. His patents reflect a commitment to improving pharmaceutical therapies and enhancing patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…